YWYuling Wang
Yuling Wang
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuling Wang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Dawen Sui
MD Anderson Cancer Center, Houston
2 shared publications - Jeffrey E. Gershenwald
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
2 shared publications - Jennifer Ann Wargo
The University of Texas MD Anderson Cancer Center
2 shared publications - Lauren E. Haydu
Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, USA
2 shared publications - Merrick I. Ross
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, US
2 shared publications - Shenying Fang
School of Public Health and Emergency Management, Southern University of Science and Technology, China
2 shared publications
Latest Publications
- Open Access
- 21 December 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (7) , 2046-2049.e3
Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker
- 21 December 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (7) , 2046-2049.e3
Open AccessEvaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker
- 1 November 2019
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 139 (11) , 2352-2358.e3
Role of Immune Response, Inflammation, and Tumor Immune Response–Related Cytokines/Chemokines in Melanoma Progression
- 1 November 2019
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 139 (11) , 2352-2358.e3
Role of Immune Response, Inflammation, and Tumor Immune Response–Related Cytokines/Chemokines in Melanoma Progression